Report of the 2010 APhA House of Delegates
Actions of the legislative body of the American Pharmacists Association

J Am Pharm Assoc (2003) 2010;50:471-472. doi:10.1331/JAPhA.2010.10525
text A A A
The following policies were adopted by the 2010 APhA House of Delegates and are now official Association policy:

Pharmacogenomics/personalized medicine

  • APhA supports evidence-based personalized medicine, defined as the use of a person's clinical, genetic, genomic, and environmental information to select a medication or its dose, to choose a therapy, or to recommend preventive measures, as a means to improve patient safety and optimize health outcomes.
  • APhA promotes pharmacists as health care providers in the collection, use, interpretation, and application of pharmacogenomic data to optimize health outcomes.
  • APhA supports the development and implementation of programs, tools, and clinical guidelines that facilitate the translation and application of pharmacogenomic data into clinical practice.
  • APhA supports the inclusion of pharmacogenomic analysis in the drug development/approval and postmarketing surveillance processes.

E-prescribing standardization

  • APhA supports the standardization of user interfaces to improve quality and reduce errors unique to e-prescribing.
  • APhA supports reporting mechanisms and research efforts to evaluate the effectiveness, safety, and quality of e-prescribing systems, computerized prescriber order entry (CPOE) systems, and the e-prescriptions that they produce, in order to improve health information technology systems and, ultimately, patient care.
  • APhA supports the development of financial incentives for pharmacists and prescribers to provide high quality e-prescribing activities.
  • APhA supports the inclusion of pharmacists in quality improvement and meaningful use activities related to the use of e-prescribing and other health information technology that would positively impact patient health outcomes.

Personal health records

  • APhA supports patient utilization of personal health records, defined as records of health-related information managed, shared, and controlled by the individual, to facilitate self-management and communication across the continuum of care.
  • APhA urges both public and private entities to identify and include pharmacists and other stakeholders in the development of personal health record systems and the adoption of standards, including but not limited to terminology, security, documentation, and coding of data contained within personal health records.
  • APhA supports the development, implementation, and maintenance of personal health record systems that are accessible and searchable by pharmacists and other health care providers, interoperable and portable across health information systems, customizable to the needs of the patient, and able to differentiate information provided by a health care provider and the patient.
  • APhA supports pharmacists taking the leadership role in educating the public about the importance of maintaining current and accurate medication-related information within personal health records.
The following new business items were adopted by the 2010 APhA House of Delegates and are now official Association policy:

Transfer coupons

APhA advocates the elimination of coupons, rebates, discounts, and other incentives provided to patients that promote the transfer of prescriptions between competitors.

Discontinuation of the sale of tobacco products in pharmacies and facilities that include pharmacies

  • APhA urges pharmacies and facilities that include pharmacies to discontinue the sale of tobacco products.
  • APhA urges the federal government and state governments to limit participation in government-funded prescription programs to pharmacies that do not sell tobacco products.
  • APhA urges state boards of pharmacy to discontinue issuing and renewing licenses to pharmacies that sell tobacco products and to pharmacies that are in facilities that sell tobacco products.
  • APhA urges colleges of pharmacy to only use pharmacies that do not sell tobacco products as experience sites for their students.
  • APhA urges the Accreditation Council for Pharmacy Education (ACPE) to adopt the position that college-administered pharmacy experience programs should only use pharmacies that do not sell tobacco products.
  • APhA urges pharmacists and student pharmacists who are seeking employment opportunities to first consider positions in pharmacies that do not sell tobacco products.

Introductory pharmacy practice experience

APhA supports a collaborative effort amongst stakeholders (e.g., professional pharmacy organizations, deans, faculty, preceptors, and student pharmacists) to develop and implement a nationally defined set of competencies to assess the successful completion of introductory pharmacy practice experiences (IPPEs). APhA believes that these competencies should reflect the professional knowledge, attitudes, and skills necessary for entry into advanced pharmacy practice experiences (APPEs).
As part of the continuing review of existing policy, the House amended, archived, and rescinded existing policy on a range of topics.
The House amended the following statements:
  • 1994 Pharmacy services benefits in health care reformAPhA supports reform of the U.S. health care system and believes that any reform at the state or national level must provide for the following:
    • universal coverage for pharmacy service benefits that include both medications and pharmacists' services;
    • specific provisions for the access to and payment for pharmaceutical care services, including, but not limited to, patient compliance and preventive care, medication therapy management (MTM) of complex and high-risk patients, health education, drug regimen review, and drug utilization review;
    • a single set of pricing rules, eliminating class-of-trade distinctions, for medications, medication delivery systems, and other equipment so that no payer, patient, or provider is disadvantaged by cost shifting.
    • the right for every American to choose his/her own provider of medications and pharmacists' services and for all pharmacists to participate in the health plans of their choice under equally applied terms and conditions;
    • quality assurance mechanisms to improve and substantiate the effectiveness of medications and health services;
    • information and administrative systems designed to enhance patient care, eliminate needless bureaucracy, and provide patients and providers price and quality information needed to make informed patient-care decisions;
    • relief from antitrust laws and regulations to enable pharmacists to establish systems that balance provider needs relative to corporate and governmental interests;
    • reform in the professional liability system, including caps on non-economic damages, attorneys' fees, and other measures;
    • representation on the controlling board of each plan by an active health care practitioner from each discipline within the scope of the plan; and
    • recognition of the pharmacist's role in delivering primary health care services.
    (Am Pharm. NS34(6):58. June 1994) (Reviewed 2004)
  • 1994 The scientific implications of health care reform
    • APhA advocates that the public and private sectors maintain or increase their level of commitment to assure adequate resources for both basic and applied research within a reformed health care system.
    • APhA encourages the public and private research communities to preferentially expend resources for the discovery and development of new drugs and technologies that provide substantive, innovative therapeutic advances.
    • APhA advocates an increased emphasis on outcomes research in all areas of health services, including drug and disease-specific research encompassing clinical, economic, and humanistic dimensions (e.g., quality of life, patient satisfaction, ethics) and advocates for action related to conclusions for such research.
    • APhA encourages interdisciplinary collaboration in research efforts within and between the public and private research communities.
    (Am Pharm. NS34(6):55. June 1994) (Reviewed 2004)
  • 1989 Patient education on medication storageAPhA supports the continued development and use of educational resources for patients regarding the proper storage of drug products.(Am Pharm. NS29(7):464. July 1989) (Reviewed 2004)
  • 2004 Poison control, information, and treatment: Pharmacists' responsibility1968 1. APhA encourages pharmacists to familiarize themselves with the available resources on poisons and toxicology.2. APhA encourages pharmacists to become familiar with the poison control, information and treatment centers in their localities.(J Am Pharm Assoc. NS8:383. July 1968) (J Am Pharm Assoc. NS44(5):551. September/October 2004)
  • 1993 Pharmacists' services
    • APhA supports development of pharmacy payment systems that include reimbursement of the cost of any medication or device provided; the cost of preparing the medication or device; the costs of administrative services; return on capital investment; and payment for both the dispensing-related and non-dispensing pharmacy services, such as medication therapy management (MTM).
    • APhA believes that appropriate incentives for the pharmacist providing care should be part of any payment system.
    (Am Pharm. NS33(7):53. July 1993) (Reviewed 2005) (Reviewed 2007)
The APhA House of Delegates adopted the report of the APhA House Rules Review Committee making modifications to its operations. The report is posted at www.pharmacist.com/hod and is also available upon request to the APhA Speaker of the House at hod@aphanet.org. The House also retained, referred, and archived statements on a range of issues and rescinded policy based upon current policy and environment. A compilation of 2010 retained, referred, and archived policy is available upon request to the Speaker of the House.
The next meeting of the APhA House of Delegates will be held in conjunction with APhA2011, March 25 and 28, 2011, in Seattle, WA. Periodic reports concerning the actions of the 2010 APhA House and information on the 2010 session will be posted at www.pharmacist.com/hod.


Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints